Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

has now listed Novo Nordisk’s blockbuster diabetes and obesity medications Wegovy and Ozempic as “available.” Semaglutide ...

The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

You need the best health care providers to ensure a proper hormone balance. Here are the top endocrinologists on.

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

“We observed reductions in participants’ anti-diabetic medications and substantial improvements in metabolic parameters. The ...